查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1825759

2025年糖化血红素（HbA1c）检测全球市场报告

Hemoglobin A1c (HbA1c) Testing Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

预计未来几年，糖化血红蛋白 (HbA1c) 检测市场将快速成长，到 2029 年将达到 30.1 亿美元，复合年增长率为 10.4%。预测期内的成长可归因于文明病盛行率的上升、对预防性医疗保健的日益重视、新兴市场的扩张、个人化医疗和以患者为中心的护理的增加、监管支持和报销政策的完善、远端医疗的扩展以及远端监控。预测期内的主要趋势包括技术进步、与数位健康平台的整合、非侵入性检测技术的进步、远距远端医疗的扩展以及远端患者监护。

未来五年的成长率预测为10.4%，较先前的预测略有下降0.2%。这一下降主要源自于美国与其他国家之间关税的影响。贸易摩擦可能导致瑞典和加拿大开发的高效液相层析(HPLC)分析仪和照护现场糖化血红蛋白(HbA1c)检测套组价格上涨，从而导致血糖控制评估延迟、内分泌检测成本上升，进而扰乱糖尿病管理。互惠关税以及贸易紧张局势和限制加剧对全球经济和贸易的负面影响可能会产生更广泛的影响。

糖尿病盛行率的上升预计将推动糖化血红蛋白 (HbA1c) 检测市场的扩张。糖尿病是一种慢性疾病，由于胰岛素分泌不足或胰岛素阻抗，身体难以调节血糖值。糖尿病患者数量的增加归因于不良饮食习惯（尤其是大量摄取加工食品和含糖饮料）以及久坐不动、缺乏运动的生活方式等因素。此外，老化和遗传易感性也会增加罹患糖尿病的可能性。 HbA1c 检测透过测量过去两到三个月的平均血糖值，对于监测长期血糖控制至关重要。例如，根据《柳叶刀》2023 年 6 月的一份报告，预计到 2050 年，全球糖尿病患者数量将从 2021 年的 5.29 亿增加到 13 亿。因此，糖尿病盛行率的上升可能会推动 HbA1c 检测市场的成长。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球糖化血红蛋白 (HbA1c) 测试：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 最终用途产业分析
  • 全球糖化血红素 (HbA1c) 检测市场：成长率分析
  • 全球糖化血红蛋白 (HbA1c) 检测市场表现：规模与成长，2019-2024 年
  • 全球糖化血红素 (HbA1c) 检测市场预测：2024-2029 年及 2034 年规模与成长
  • 全球糖化血红蛋白 (HbA1c) 检测：总潜在市场 (TAM)

第六章 市场细分

  • 全球糖化血红蛋白 (HbA1c) 检测市场：按类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 实验室检测
  • 照护现场检验 (POC)
  • 全球糖化血红蛋白 (HbA1c) 检测市场：按产品类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 装置
  • 试剂
  • 套件
  • 全球糖化血红蛋白 (HbA1c) 检测市场：按技术、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 免疫检测
  • 层析法
  • 酵素测定
  • 硼酸盐亲和层析法
  • 高效液相层析
  • 其他技术
  • 全球糖化血红蛋白 (HbA1c) 检测市场：按最终用户、实际结果和预测，2019-2024 年、2024-2029 年、2034 年
  • 医院和诊所
  • 诊断实验室
  • 居家照护环境
  • 其他最终用户
  • 全球糖化血红素 (HbA1c) 检测市场：按实验室检测（类型）细分、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 高效液相层析（HPLC）测试
  • 离子交换层析法
  • 毛细管电泳
  • 酵素免疫分析法（ELISA）
  • 质谱法
  • 全球糖化血红素 (HbA1c) 检测市场：照护现场(PoC) 检测类型细分、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 指尖采血测试装置
  • 可携式糖化血红素分析仪
  • 手持式 Hba1c检测套组
  • 家用糖化血红素监测设备
  • 无线 Hba1c 检测解决方案

第七章 区域和国家分析

  • 全球糖化血红素 (HbA1c) 检测市场：按地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 全球糖化血红素 (HbA1c) 检测市场：依国家、地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章：西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

  • 糖化血红素 (HbA1c) 检测市场：竞争格局
  • 糖化血红素 (HbA1c) 检测市场：公司简介
    • Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Siemens Healthineers Overview, Products and Services, Strategy and Financial Analysis

第31章：其他领先和创新企业

  • Tosoh Corporation
  • Hitachi High-Technologies Corporation
  • Beckman Coulter Inc
  • Sysmex Corporation
  • Bio Rad Laboratories Inc
  • ARKRAY Inc
  • Randox Laboratories Ltd
  • Ortho Clinical Diagnostics
  • Agappe Diagnostics Ltd
  • SEKISUI Diagnostics LLC
  • Helena Laboratories
  • Transasia Bio Medicals Ltd
  • EKF Diagnostics
  • Trinity Biotech plc
  • HemoCue AB

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章：高潜力市场国家、细分市场与策略

  • 2029 年糖化血红素 (HbA1c) 检测市场：哪些国家将提供新机会
  • 2029 年糖化血红蛋白 (HbA1c) 检测市场：细分市场带来新机会
  • 2029 年糖化血红素 (HbA1c) 检测市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章 附录

简介目录
Product Code: r30371u

Hemoglobin A1c (HbA1c) testing measures the percentage of hemoglobin with glucose attached, providing an indication of average blood glucose levels over the past 2 to 3 months. It is used to monitor long-term glucose control in diabetic patients and to diagnose diabetes and prediabetes.

The main types of HbA1c testing are laboratory-based testing and point-of-care (PoC) testing. Laboratory-based testing is conducted in a lab setting where blood samples are analyzed using advanced equipment. Product types for this testing include instruments, reagents, kits, and technologies. These technologies encompass immunoassays, chromatography, enzymatic assays, boronate affinity chromatography, high-performance liquid chromatography, and others. End users of HbA1c testing include hospitals and clinics, diagnostic laboratories, homecare settings, and other medical environments.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The hemoglobin A1c (HbA1c) testing market research report is one of a series of new reports from the business research company that provides hemoglobin A1c (HbA1c) testing market statistics, including hemoglobin A1c (HbA1c) testing industry global market size, regional shares, competitors with an hemoglobin A1c (HbA1c) testing market share, detailed hemoglobin A1c (HbA1c) testing market segments, market trends and opportunities, and any further data you may need to thrive in the hemoglobin A1c (HbA1c) testing industry. This hemoglobin A1c (HbA1c) testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The hemoglobin a1c (hba1c) testing market size has grown rapidly in recent years. It will grow from $1.83 billion in 2024 to $2.02 billion in 2025 at a compound annual growth rate (CAGR) of 10.4%. The growth in the historic period can be attributed to the increasing prevalence of diabetes, growing awareness and screening programs, growing government initiatives and healthcare policies, increasing healthcare infrastructure development, a growing aging population, improved diagnostic accuracy, and increased adoption of point-of-care testing.

The hemoglobin a1c (hba1c) testing market size is expected to see rapid growth in the next few years. It will grow to $3.01 billion in 2029 at a compound annual growth rate (CAGR) of 10.4%. The growth in the forecast period can be attributed to rising prevalence of lifestyle diseases, increased focus on preventive healthcare, expansion in emerging markets, increasing personalized medicine and patient-centric care, regulatory support and reimbursement policies, growing telemedicine, and remote monitoring. Major trends in the forecast period include technological advancements, integration with digital health platforms, advancements in non-invasive testing technologies, expansion in telehealth, and remote patient monitoring.

The forecast of 10.4% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could hinder diabetes management by inflating prices of High-Performance Liquid Chromatography(HPLC) analyzers and point-of-care HbA1c test kits developed in Sweden and Canada, resulting in delayed glycemic control assessments and higher endocrinology testing costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The growing prevalence of diabetes is expected to drive the expansion of the hemoglobin A1c (HbA1c) testing market. Diabetes is a chronic condition where the body struggles to regulate blood glucose levels due to inadequate insulin production or insulin resistance. The rise in diabetes cases is attributed to factors such as poor diet-particularly high consumption of processed foods and sugary drinks-and sedentary lifestyles with minimal physical activity. Additionally, the aging population and genetic predisposition increase the likelihood of developing diabetes. HbA1c testing is essential for monitoring long-term blood glucose control by measuring average blood sugar levels over the past 2-3 months. For example, data from The Lancet in June 2023 projected that global diabetes cases would grow from 529 million in 2021 to 1.3 billion by 2050. Consequently, the increasing prevalence of diabetes will fuel the growth of the HbA1c testing market.

Leading companies in the HbA1c testing market are concentrating on developing automated analyzers, such as those using high-performance liquid chromatography (HPLC) technology, to improve accuracy and efficiency in diabetes diagnosis and monitoring. HPLC-based solutions are advanced methods for precisely measuring hemoglobin variants in blood, which helps in monitoring long-term glucose control in diabetic patients. For instance, in June 2021, Trivitron Healthcare Private Limited, an India-based medical technology company, introduced the NANO H5 and NANO H110. The NANO H5 is a compact, automated HPLC analyzer that quantifies glycated hemoglobin (HbA1c) in whole blood with a processing time of 130 seconds, allowing for rapid laboratory results and the capability to process up to five samples simultaneously. The NANO H110 is another compact, automated HPLC analyzer with dual test modes for both HbA1c and Hb Variant detection. It features advanced components such as a barcode scanner and cap piercing, with a high sample capacity of 110, making it suitable for medium to large laboratories.

In January 2024, Roche Holding AG, a Swiss pharmaceutical and diagnostics company, acquired point-of-care (POC) technology from LumiraDx for $350 million. This acquisition aims to expand Roche's diagnostics portfolio and enhance its capabilities in decentralized healthcare settings, providing quick and reliable tests, including the CE-marked HbA1c test, without requiring specialized storage. LumiraDx is a UK-based company specializing in point-of-care (POC) technology and offering immunoassay and clinical chemistry tests for HbA1c.

Major companies operating in the hemoglobin A1c (HbA1c) testing market are Roche Holding AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers, Tosoh Corporation, Hitachi High-Technologies Corporation, Beckman Coulter Inc, Sysmex Corporation, Bio Rad Laboratories Inc, ARKRAY Inc, Randox Laboratories Ltd, Ortho Clinical Diagnostics, Agappe Diagnostics Ltd, SEKISUI Diagnostics LLC, Helena Laboratories, Transasia Bio Medicals Ltd, EKF Diagnostics, Trinity Biotech plc, HemoCue AB, CPC Diagnostics Pvt Ltd, PTS Diagnostics, Menarini Diagnostics srl, Diazyme Laboratories Inc, Osang HealthCare Co Ltd, Eurolyser Diagnostica GmbH, DiaSys Diagnostic Systems GmbH

North America was the largest region in the hemoglobin A1c (HbA1c) testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hemoglobin A1c (HbA1c) testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the hemoglobin A1c (HbA1c) testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The hemoglobin A1c (HbA1c) testing market consists of revenues earned by entities by providing services such as home monitoring services, remote patient monitoring solutions, specialized HbA1c assay development, telehealth HbA1c monitoring, and personalized treatment management consulting. The market value includes the value of related goods sold by the service provider or included within the service offering. The hemoglobin A1c (HbA1c) testing market also includes sales of diagnostic reagents, test cartridges, automated analyzers, and calibration standards. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Hemoglobin A1c (HbA1c) Testing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on hemoglobin a1c (hba1c) testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for hemoglobin a1c (hba1c) testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The hemoglobin a1c (hba1c) testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Laboratory Based Testing; Point Of Care (PoC) Testing
  • 2) By Product Type: Instruments; Reagents; Kits
  • 3) By Technology: Immunoassays; Chromatography; Enzymatic Assays; Boronate Affinity Chromatography; High Performance Liquid Chromatography; Other Technologies
  • 4) By End User: Hospitals And Clinics; Diagnostic Laboratories; Homecare Settings; Other End Users
  • Subsegments:
  • 1) By Laboratory-Based Testing: High-Performance Liquid Chromatography (HPLC) Testing; Ion-Exchange Chromatography; Capillary Electrophoresis; Enzyme-Linked Immunosorbent Assay (ELISA); Mass Spectrometry
  • 2) By Point Of Care (PoC) Testing: Fingerstick Testing Devices; Portable Hba1c Analyzers; Handheld Hba1c Test Kits; Home Use Hba1c Monitoring Devices; Wireless Hba1c Testing Solutions
  • Companies Mentioned: Roche Holding AG; Thermo Fisher Scientific Inc.; Abbott Laboratories; Danaher Corporation; Siemens Healthineers; Tosoh Corporation; Hitachi High-Technologies Corporation; Beckman Coulter Inc; Sysmex Corporation; Bio Rad Laboratories Inc; ARKRAY Inc; Randox Laboratories Ltd; Ortho Clinical Diagnostics; Agappe Diagnostics Ltd; SEKISUI Diagnostics LLC; Helena Laboratories; Transasia Bio Medicals Ltd; EKF Diagnostics; Trinity Biotech plc; HemoCue AB; CPC Diagnostics Pvt Ltd; PTS Diagnostics; Menarini Diagnostics srl; Diazyme Laboratories Inc; Osang HealthCare Co Ltd; Eurolyser Diagnostica GmbH; DiaSys Diagnostic Systems GmbH
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Hemoglobin A1c (HbA1c) Testing Market Characteristics

3. Hemoglobin A1c (HbA1c) Testing Market Trends And Strategies

4. Hemoglobin A1c (HbA1c) Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Hemoglobin A1c (HbA1c) Testing Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Hemoglobin A1c (HbA1c) Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Hemoglobin A1c (HbA1c) Testing Market Growth Rate Analysis
  • 5.4. Global Hemoglobin A1c (HbA1c) Testing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Hemoglobin A1c (HbA1c) Testing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Hemoglobin A1c (HbA1c) Testing Total Addressable Market (TAM)

6. Hemoglobin A1c (HbA1c) Testing Market Segmentation

  • 6.1. Global Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Laboratory Based Testing
  • Point Of Care (Poc) Testing
  • 6.2. Global Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Instruments
  • Reagents
  • Kits
  • 6.3. Global Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Immunoassays
  • Chromatography
  • Enzymatic Assays
  • Boronate Affinity Chromatography
  • High Performance Liquid Chromatography
  • Other Technologies
  • 6.4. Global Hemoglobin A1c (HbA1c) Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals And Clinics
  • Diagnostic Laboratories
  • Homecare Settings
  • Other End Users
  • 6.5. Global Hemoglobin A1c (HbA1c) Testing Market, Sub-Segmentation Of Laboratory-Based Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • High-Performance Liquid Chromatography (HPLC) Testing
  • Ion-Exchange Chromatography
  • Capillary Electrophoresis
  • Enzyme-Linked Immunosorbent Assay (ELISA)
  • Mass Spectrometry
  • 6.6. Global Hemoglobin A1c (HbA1c) Testing Market, Sub-Segmentation Of Point Of Care (PoC) Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Fingerstick Testing Devices
  • Portable Hba1c Analyzers
  • Handheld Hba1c Test Kits
  • Home Use Hba1c Monitoring Devices
  • Wireless Hba1c Testing Solutions

7. Hemoglobin A1c (HbA1c) Testing Market Regional And Country Analysis

  • 7.1. Global Hemoglobin A1c (HbA1c) Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Hemoglobin A1c (HbA1c) Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Hemoglobin A1c (HbA1c) Testing Market

  • 8.1. Asia-Pacific Hemoglobin A1c (HbA1c) Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Hemoglobin A1c (HbA1c) Testing Market

  • 9.1. China Hemoglobin A1c (HbA1c) Testing Market Overview
  • 9.2. China Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Hemoglobin A1c (HbA1c) Testing Market

  • 10.1. India Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Hemoglobin A1c (HbA1c) Testing Market

  • 11.1. Japan Hemoglobin A1c (HbA1c) Testing Market Overview
  • 11.2. Japan Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Hemoglobin A1c (HbA1c) Testing Market

  • 12.1. Australia Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Hemoglobin A1c (HbA1c) Testing Market

  • 13.1. Indonesia Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Hemoglobin A1c (HbA1c) Testing Market

  • 14.1. South Korea Hemoglobin A1c (HbA1c) Testing Market Overview
  • 14.2. South Korea Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Hemoglobin A1c (HbA1c) Testing Market

  • 15.1. Western Europe Hemoglobin A1c (HbA1c) Testing Market Overview
  • 15.2. Western Europe Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Hemoglobin A1c (HbA1c) Testing Market

  • 16.1. UK Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Hemoglobin A1c (HbA1c) Testing Market

  • 17.1. Germany Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Hemoglobin A1c (HbA1c) Testing Market

  • 18.1. France Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Hemoglobin A1c (HbA1c) Testing Market

  • 19.1. Italy Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Hemoglobin A1c (HbA1c) Testing Market

  • 20.1. Spain Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Hemoglobin A1c (HbA1c) Testing Market

  • 21.1. Eastern Europe Hemoglobin A1c (HbA1c) Testing Market Overview
  • 21.2. Eastern Europe Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Hemoglobin A1c (HbA1c) Testing Market

  • 22.1. Russia Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Hemoglobin A1c (HbA1c) Testing Market

  • 23.1. North America Hemoglobin A1c (HbA1c) Testing Market Overview
  • 23.2. North America Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Hemoglobin A1c (HbA1c) Testing Market

  • 24.1. USA Hemoglobin A1c (HbA1c) Testing Market Overview
  • 24.2. USA Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Hemoglobin A1c (HbA1c) Testing Market

  • 25.1. Canada Hemoglobin A1c (HbA1c) Testing Market Overview
  • 25.2. Canada Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Hemoglobin A1c (HbA1c) Testing Market

  • 26.1. South America Hemoglobin A1c (HbA1c) Testing Market Overview
  • 26.2. South America Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Hemoglobin A1c (HbA1c) Testing Market

  • 27.1. Brazil Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Hemoglobin A1c (HbA1c) Testing Market

  • 28.1. Middle East Hemoglobin A1c (HbA1c) Testing Market Overview
  • 28.2. Middle East Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Hemoglobin A1c (HbA1c) Testing Market

  • 29.1. Africa Hemoglobin A1c (HbA1c) Testing Market Overview
  • 29.2. Africa Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Hemoglobin A1c (HbA1c) Testing Market Competitive Landscape And Company Profiles

  • 30.1. Hemoglobin A1c (HbA1c) Testing Market Competitive Landscape
  • 30.2. Hemoglobin A1c (HbA1c) Testing Market Company Profiles
    • 30.2.1. Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Siemens Healthineers Overview, Products and Services, Strategy and Financial Analysis

31. Hemoglobin A1c (HbA1c) Testing Market Other Major And Innovative Companies

  • 31.1. Tosoh Corporation
  • 31.2. Hitachi High-Technologies Corporation
  • 31.3. Beckman Coulter Inc
  • 31.4. Sysmex Corporation
  • 31.5. Bio Rad Laboratories Inc
  • 31.6. ARKRAY Inc
  • 31.7. Randox Laboratories Ltd
  • 31.8. Ortho Clinical Diagnostics
  • 31.9. Agappe Diagnostics Ltd
  • 31.10. SEKISUI Diagnostics LLC
  • 31.11. Helena Laboratories
  • 31.12. Transasia Bio Medicals Ltd
  • 31.13. EKF Diagnostics
  • 31.14. Trinity Biotech plc
  • 31.15. HemoCue AB

32. Global Hemoglobin A1c (HbA1c) Testing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Hemoglobin A1c (HbA1c) Testing Market

34. Recent Developments In The Hemoglobin A1c (HbA1c) Testing Market

35. Hemoglobin A1c (HbA1c) Testing Market High Potential Countries, Segments and Strategies

  • 35.1 Hemoglobin A1c (HbA1c) Testing Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Hemoglobin A1c (HbA1c) Testing Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Hemoglobin A1c (HbA1c) Testing Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer